Mark Thierer served as the Interim CEO of DENTSPLY SIRONA from September 2017 until February 2018. Before this role, he was the CEO of OptumRx, a prominent pharmacy care services company. Thierer holds significant experience in the healthcare sector, especially...
Mark Thierer served as the Interim CEO of DENTSPLY SIRONA from September 2017 until February 2018. Before this role, he was the CEO of OptumRx, a prominent pharmacy care services company. Thierer holds significant experience in the healthcare sector, especially in pharmacy, having also led Catamaran Corporation, one of the major pharmacy benefit managers in the U.S. His previous tenure saw the company merge with OptumRx in 2015, showcasing his leadership in important business transformations. While at DENTSPLY SIRONA, Thierer was awarded a sizable compensation package, including an impressive signing bonus of $2.5 million. His strategic decisions affected the company's performance metrics which focused on both sales growth and profitability. Interestingly, during his time, Thierer also engaged in substantial insider trading activities, peaking with $9.41 million in shares held in May 2021, reflecting his commitment and belief in the company's future. He knows the pharmacy landscape and has been recognized for his role in integrating healthcare services, which translates into valuable insights for DENTSPLY as they navigate their market challenges.